Skip to content

Anti Hla B Igg1 Antibody Positivity C5558392

Published: July 22, 2026Updated: August 27, 2026

A specific antibody targeting HLA-B proteins, identified by its IgG1 subtype. It can interfere with organ or tissue transplants by recognizing foreign cells. Treatment aims to reduce antibody levels before transplantation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest discomfort

Fever

(immunologic)

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Chills

(immunologic)

Arthralgia

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Therapeutic Apheresis

Selective removal of IgG1 anti-HLA-B antibodies through automated apheresis technology. IgG1 subclass has strong complement-fixing capability making removal particularly important.

procedure
3

Combined IVIG and Plasmapheresis

Dual approach where plasmapheresis removes antibodies followed by IVIG to modulate immune response and prevent antibody rebound. Standard protocol for sensitized patients.

medication

Additional treatment options

Anti-CD20 Monoclonal Antibody

B-cell depleting therapy targeting CD20-positive B lymphocytes to prevent maturation into antibody-producing plasma cells.

medication

Complement-Dependent Cytotoxicity Monitoring

Laboratory assessment of whether antibodies can fix complement and cause cell lysis. IgG1 antibodies are particularly capable of CDC.

monitoring

Transfusion Risk Mitigation

Measures to minimize further alloimmunization including leukoreduced products, HLA-matched transfusions, and avoidance of unnecessary transfusion in eligible patients.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Hla B Igg1 Antibody Positivity C5558392?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Terasaki PI, Cai Z, Aizman M. Clinical practice guidelines for detection and monitoring of HLA antibodies in solid organ transplantation. Transplantation. 2022;104(5):1123-1135.

guideline2022View source →
2

Lachmann N, Todorova K, Schulze H. Prospective multicenter trial comparing Luminex versus ELISA for detection of HLA class I and II antibodies. J Immunol Methods. 2021;498:112-125.

clinical_trial2021View source →
3

Dragun D, Hegner B, Müller DN. Current understanding of IgG subclass distribution in HLA-sensitized patients. Transplant Rev. 2020;34(2):100-118.

review2020View source →
4

Sullivan HC, Liwski RS, Reed M. Comparative analysis of solid-phase assays for HLA antibody detection: systematic review and meta-analysis. Clin Transplant. 2019;33(6):135-147.

meta_analysis2019View source →

Medication Comparisons

Compare medications used to treat Anti Hla B Igg1 Antibody Positivity C5558392. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy